| Product Name | Dacomitinib - API |
| Product Code | DA-B007-03 |
| Chemical name | Dacomitinib |
| Synonyms | (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide; (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quizolinyl]-4-(1-piperidinyl)-2-butenamide; |
| Impurity | NA |
| CAS Number | 1110813-31-4 |
| Alternate CAS # | NA |
| Molecular form | C24H25ClFN5O2 |
| Appearance | White to Pale Yellow Solid |
| Melting Point | NA |
| Mol. Weight | 469.95 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | pharmaceutical standards,impurities,intermediates,metabolites,fine chemicals |
| Boiling Point | NA |
| Applications | Dacomitinib is an Erb-inhibitor, or an inhibitor of the members of the epidermal growth factor receptor family. Used as an ant-cancer agent due to observation of over-expressed epidermal growth factor receptor in nearly all cases of squamous cell carcinoma in the head and neck. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
